Welcome Letter From John 
Welcome to the CIG website. We are glad that you found us, and trust that you will find the information presented useful, whether you are a newly diagnosed patient, or an experienced one. In the world of non-Hodgkin lymphomas, chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are often under represented. In order to gather more information, patients who have become affected by this blood disorder need to group together and become more “visible” and vocal in the medical community. As a collective group, we’ll be in a better position to raise CLL/SLL awareness and better request resources dedicated to our needs.
New This Month
Glossary of Medical Terms and Acronyms
This glossary is designed to serve as a reference for CLL/SLL patients.
Lymphoma Workshop - Scottsdale, Arizona
On Saturday, March 6, 2010, CIG will host two special breakout sessions on CLL/SLL featuring John Pagel, MD, PhD (Fred Hutchinson Cancer Research Center) at this full day educational program for patients and survivors. Register today!
New Online Resource for CLL Patients and Survivors
View this free webcast program today.
Advances in the Treatment of Chronic Lymphocytic Leukemia
On February 10, 2010, CancerCare, in collaboration with CIG, will host a free teleconference for CLL patients, survivors and loved ones featuring Michael Keating, MB, BS and Clive Zent, MD. Register today!
FDA Approves New Treatment for CLL
On October 26, 2009, the U.S. Food and Drug Administration approved ofatumumab (Arzerra) for the treatment of chronic lymphocytic leukemia (CLL).
CLL Research Grants Awarded
Lymphoma Research Foundation announced the second round of funding awarded to David Frank, MD, PhD (Dana-Farber Cancer Institute) and Thomas Kipps, MD, PhD (Moores Cancer Center, University of California, San Diego).
CIG Teleconference - Michael Keating, MB
On April 2, 2009, CIG hosted a teleconference for CLL/SLL Patients featuring Dr. Michael Keating (MD Anderson Cancer Center).
CIG Teleconference - Richard Furman, MD
On August 24, 2009 CIG hosted a teleconference for CLL/SLL patients featuring Dr. Richard Furman (Weill Cornell Medical College, New York-Presbyterian Hospital). Please note: The Q&A from the call is truncated.
Subscribe to CLL/SLL Discussion Group
Join today to be part of a medically oriented discussion group with over 500 members- some newly diagnosed and some very experienced- who share their knowledge with you. The group is joined by Dr. Richard Furman, our medical advisor.
CLL Challenge Grant - $1.5 Million
The Lymphoma Research Foundation has received a $1.5 million CLL Challenge Grant from a generous donor as a result of the partnership with CIG. Contributions will be matched dollar for dollar.
CLL/SLL Publication - Order Your Free Copy Today
A CLL/SLL-specific publication, Research In Focus: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, is available for free.
New This Month Archive
Subscribe to CLL/SLL Discussion Group
CIG is not a discussion group; it is a patient advocacy group that dispenses disease-specific information to people with CLL/SLL and their loved ones. However, we do have a related group where frequent and interesting discussions do take place. Richard Furman, MD, a CLL expert from Weill Medical College of Cornell University and New York-Presbyterian, is now active on this discussion group, so we have an important medical advisor on board. Subscribe to the discussion group today.
Join CIG
To receive regular updates from us about new content, news, and upcoming programs and events, please Join CIG.
back to top
